tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SNYNF Stock Latest News

Sanofi’s Promising Growth Prospects: Buy Rating Backed by Brivekimig and Tolebrutinib Potential
RatingsSanofi’s Promising Growth Prospects: Buy Rating Backed by Brivekimig and Tolebrutinib Potential
3d ago
SNY
Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
PremiumThe Fly
Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
8d ago
DV
ES
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
PremiumThe Fly
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
10d ago
DV
AZN
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
PremiumThe Fly
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
10d ago
AZN
BMY
Trump Trade: U.S. President signs new pharma order
PremiumThe Fly
Trump Trade: U.S. President signs new pharma order
10d ago
DV
AZN
Trump signs memorandum mandating pharma ads give more info on risks
PremiumThe FlyTrump signs memorandum mandating pharma ads give more info on risks
11d ago
AZN
BMY
Sanofi’s Amlitelimab: Buy Rating Amid Challenges and Opportunities in Atopic Dermatitis Market
Premium
Ratings
Sanofi’s Amlitelimab: Buy Rating Amid Challenges and Opportunities in Atopic Dermatitis Market
12d ago
SNY
Sanofi upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Sanofi upgraded to Overweight from Equal Weight at Morgan Stanley
12d ago
SNY
Sanofi’s Promising Ulcerative Colitis Study: What Investors Need to Know
PremiumCompany Announcements
Sanofi’s Promising Ulcerative Colitis Study: What Investors Need to Know
13d ago
SNYNF
Sanofi’s Promising Crohn’s Disease Study: What Investors Need to Know
PremiumCompany Announcements
Sanofi’s Promising Crohn’s Disease Study: What Investors Need to Know
13d ago
SNYNF
Sanofi’s Amlitelimab Study: A Potential Game-Changer for Atopic Dermatitis
PremiumCompany Announcements
Sanofi’s Amlitelimab Study: A Potential Game-Changer for Atopic Dermatitis
13d ago
SNYNF
Sanofi’s Promising Phase 3 Study on Frexalimab for Multiple Sclerosis
PremiumCompany Announcements
Sanofi’s Promising Phase 3 Study on Frexalimab for Multiple Sclerosis
13d ago
SNYNF
Sanofi’s Frexalimab Study: A Potential Game-Changer for Multiple Sclerosis Treatment
PremiumCompany AnnouncementsSanofi’s Frexalimab Study: A Potential Game-Changer for Multiple Sclerosis Treatment
13d ago
SNYNF
Sanofi’s New Study on Amlitelimab Delivery: What Investors Need to Know
Premium
Company Announcements
Sanofi’s New Study on Amlitelimab Delivery: What Investors Need to Know
13d ago
SNYNF
Sanofi’s Amlitelimab Study: A Potential Game-Changer for Atopic Dermatitis Treatment
Premium
Company Announcements
Sanofi’s Amlitelimab Study: A Potential Game-Changer for Atopic Dermatitis Treatment
13d ago
SNYNF
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Eosinophilic Gastritis
PremiumCompany Announcements
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Eosinophilic Gastritis
13d ago
REGN
Sanofi’s Latest Clinical Study: A New Hope for Advanced Solid Tumors
PremiumCompany Announcements
Sanofi’s Latest Clinical Study: A New Hope for Advanced Solid Tumors
13d ago
SNYNF
Sanofi’s Promising Phase 2a/b Study on Amlitelimab for Celiac Disease
PremiumCompany Announcements
Sanofi’s Promising Phase 2a/b Study on Amlitelimab for Celiac Disease
13d ago
SNYNF
Sanofi’s Promising New Study on Rilzabrutinib for ITP: A Potential Game-Changer
PremiumCompany Announcements
Sanofi’s Promising New Study on Rilzabrutinib for ITP: A Potential Game-Changer
13d ago
SNYNF
Sanofi’s Nirsevimab Study: A Promising Step in RSV Prevention
PremiumCompany AnnouncementsSanofi’s Nirsevimab Study: A Promising Step in RSV Prevention
13d ago
SNYNF
Sanofi’s New Phase IV Trial: A Step Forward in cGVHD Treatment
Premium
Company Announcements
Sanofi’s New Phase IV Trial: A Step Forward in cGVHD Treatment
13d ago
SNYNF
Sanofi’s New Vaccine Study: A Potential Game-Changer in Meningococcal Prevention
Premium
Company Announcements
Sanofi’s New Vaccine Study: A Potential Game-Changer in Meningococcal Prevention
13d ago
SNYNF

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >